BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4
35 results:

  • 1. pancreatic index: A prognostic factor of upfront surgery for body or tail pancreatic ductal adenocarcinoma with vascular involvement-A retrospective study.
    Qian L; Li J; Sun Y; Chai W; Deng X; Wang W; Shen B
    Cancer Med; 2023 Dec; 12(23):21199-21208. PubMed ID: 37933476
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Trapping all ERBB ligands decreases pancreatic lesions in a murine model of pancreatic ductal adenocarcinoma.
    Hedegger K; Blutke A; Hommel T; Auer KE; Nataraj NB; Lindzen M; Yarden Y; Dahlhoff M
    Mol Oncol; 2023 Nov; 17(11):2415-2431. PubMed ID: 37341059
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket Study.
    Salawu A; Hansen AR; Spreafico A; Al-Ezzi E; Webster S; Bedard PL; Doi J; Wang L; Siu LL; Abdul Razak AR
    Target Oncol; 2022 May; 17(3):271-281. PubMed ID: 35635640
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. High tumor mutational burden (TMB) identifies a microsatellite stable pancreatic cancer subset with prolonged survival and strong anti-tumor immunity.
    Karamitopoulou E; Andreou A; Wenning AS; Gloor B; Perren A
    Eur J Cancer; 2022 Jul; 169():64-73. PubMed ID: 35512587
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) and their Role in the Treatment of cancer: A Review.
    Unnisa A; Chettupalli AK; Hussain T; Kamal MA
    Anticancer Agents Med Chem; 2022; 22(20):3370-3381. PubMed ID: 35400324
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Validity of claims-based algorithms for selected cancers in Japan: Results from the VALIDATE-J study.
    de Luise C; Sugiyama N; Morishima T; Higuchi T; Katayama K; Nakamura S; Chen H; Nonnenmacher E; Hase R; Jinno S; Kinjo M; Suzuki D; Tanaka Y; Setoguchi S
    Pharmacoepidemiol Drug Saf; 2021 Sep; 30(9):1153-1161. PubMed ID: 33960542
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Improving Gemcitabine Sensitivity in pancreatic cancer Cells by Restoring miRNA-217 Levels.
    Panebianco C; Trivieri N; Villani A; Terracciano F; Latiano TP; Potenza A; Perri F; Binda E; Pazienza V
    Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33925948
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer.
    Khan T; Seddon AM; Dalgleish AG; Khelwatty S; Ioannou N; Mudan S; Modjtahedi H
    Oncol Rep; 2020 Dec; 44(6):2581-2594. PubMed ID: 33125153
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Unraveling ERBB network dynamics upon betacellulin signaling in pancreatic ductal adenocarcinoma in mice.
    Hedegger K; Algül H; Lesina M; Blutke A; Schmid RM; Schneider MR; Dahlhoff M
    Mol Oncol; 2020 Aug; 14(8):1653-1669. PubMed ID: 32335999
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The role of erbb4 in cancer.
    Segers VFM; Dugaucquier L; Feyen E; Shakeri H; De Keulenaer GW
    Cell Oncol (Dordr); 2020 Jun; 43(3):335-352. PubMed ID: 32219702
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer.
    Ogier C; Colombo PE; Bousquet C; Canterel-Thouennon L; Sicard P; Garambois V; Thomas G; Gaborit N; Jarlier M; Pirot N; Pugnière M; Vie N; Gongora C; Martineau P; Robert B; Pèlegrin A; Chardès T; Larbouret C
    Cancer Lett; 2018 Sep; 432():227-236. PubMed ID: 29935372
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. erbb4 promotes the proliferation of gastric cancer cells via the PI3K/Akt signaling pathway.
    Xu J; Gong L; Qian Z; Song G; Liu J
    Oncol Rep; 2018 Jun; 39(6):2892-2898. PubMed ID: 29620274
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. miR-551b regulates epithelial-mesenchymal transition and metastasis of gastric cancer by inhibiting erbb4 expression.
    Song G; Zhang H; Chen C; Gong L; Chen B; Zhao S; Shi J; Xu J; Ye Z
    Oncotarget; 2017 Jul; 8(28):45725-45735. PubMed ID: 28501849
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cervical small cell neuroendocrine tumor mutation profiles via whole exome sequencing.
    Cho SY; Choi M; Ban HJ; Lee CH; Park S; Kim H; Kim YS; Lee YS; Lee JY
    Oncotarget; 2017 Jan; 8(5):8095-8104. PubMed ID: 28042953
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The prognostic significance of human epidermal growth factor receptor family protein expression in operable pancreatic cancer : HER1-4 protein expression and prognosis in pancreatic cancer.
    Li Q; Zhang L; Li X; Yan H; Yang L; Li Y; Li T; Wang J; Cao B
    BMC Cancer; 2016 Nov; 16(1):910. PubMed ID: 27871278
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The hepatitis B virus X protein promotes pancreatic cancer through modulation of the PI3K/AKT signaling pathway.
    Chen Y; Bai X; Zhang Q; Wen L; Su W; Fu Q; Sun X; Lou Y; Yang J; Zhang J; Chen Q; Wang J; Liang T
    Cancer Lett; 2016 Sep; 380(1):98-105. PubMed ID: 27339327
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes.
    Basturk O; Tan M; Bhanot U; Allen P; Adsay V; Scott SN; Shah R; Berger MF; Askan G; Dikoglu E; Jobanputra V; Wrzeszczynski KO; Sigel C; Iacobuzio-Donahue C; Klimstra DS
    Mod Pathol; 2016 Sep; 29(9):1058-69. PubMed ID: 27282351
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Profiling of cMET and HER Family Receptor Expression in pancreatic Ductal Adenocarcinomas and Corresponding Lymph Node Metastasis to Assess Relevant Pathways for Targeted Therapies: Looking at the Soil Before Planting the Seed.
    Muckenhuber A; Babitzki G; Thomas M; Hölzlwimmer G; Zajac M; Jesinghaus M; Bergmann F; Werner J; Stenzinger A; Weichert W
    Pancreas; 2016 Sep; 45(8):1167-74. PubMed ID: 26825865
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer.
    Modjtahedi H; Cho BC; Michel MC; Solca F
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Jun; 387(6):505-21. PubMed ID: 24643470
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The ABC of BTC: structural properties and biological roles of betacellulin.
    Dahlhoff M; Wolf E; Schneider MR
    Semin Cell Dev Biol; 2014 Apr; 28():42-8. PubMed ID: 24440602
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.